Correlation Between Adaptimmune Therapeutics and Calithera Biosciences
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Calithera Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Calithera Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Calithera Biosciences, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Calithera Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Calithera Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Calithera Biosciences.
Diversification Opportunities for Adaptimmune Therapeutics and Calithera Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Adaptimmune and Calithera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Calithera Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calithera Biosciences and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Calithera Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calithera Biosciences has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Calithera Biosciences go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Calithera Biosciences
If you would invest 71.00 in Adaptimmune Therapeutics Plc on November 9, 2024 and sell it today you would lose (10.00) from holding Adaptimmune Therapeutics Plc or give up 14.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Calithera Biosciences
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Calithera Biosciences |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Adaptimmune Therapeutics and Calithera Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Calithera Biosciences
The main advantage of trading using opposite Adaptimmune Therapeutics and Calithera Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Calithera Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calithera Biosciences will offset losses from the drop in Calithera Biosciences' long position.The idea behind Adaptimmune Therapeutics Plc and Calithera Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Calithera Biosciences vs. Abeona Therapeutics | Calithera Biosciences vs. Affimed NV | Calithera Biosciences vs. Checkpoint Therapeutics | Calithera Biosciences vs. Adaptimmune Therapeutics Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |